IND
Investigational New Drug Application (USA) Formal means by which a company requests permission from the FDA to expose people to an experimental drug compound for clinical trials.
a form submitted by a company as a request for FDAis permission to expose healthy human volunteers to an experimental drug; must be filed for each clinical trial performed, phases 1-3.